0 0 0 0 -0 0 0 2 -4 9 1 2 -4 2 6 1 Rafael C. Freire, 1,2 0 0 0 0 -0 0 0 2 -4 9 1 2 -4 2 6 1 Jeffrey P. Kahn 3 0 0 0 0 -0 0 0 2 -4 9 1 2 -4 2 6 1
A master of clinical psychopharmacology, Professor Donald Franklin Klein - 3, 4 in the Brazilian Journal of Psychiatry.
After graduating from medical school, Donald Klein completed a Public Health Service internship, then a firstyear residency at the Creedmoor Psychiatric Center in Queens. He then returned to the Public Health Service for a stint at the Narcotic Farm in Lexington, Kentucky. There he worked under Abraham Wikler, who was exploring the relationship between physiology, neurology, and addiction; Professor Klein conducted several drug trials. After 2 years, he returned to Creedmoor. In the late 1950s, he joined Zucker Hillside Hospital in Queens, known as a hotbed of psychiatric research. There, working under Max Fink, Professor Klein became increasingly interested in psychopharmacology, collecting data on the effects of drugs on various conditions. He noticed that, when patients with a peculiar kind of anxiety attack that included agoraphobia were given imipramine, their panic attacks subsided. He was a leading proponent of using ''pharmacological dissection'' as a tool to subtype anxiety, depressive, and other psychiatric disorders. A detailed account of this history is included in his foreword to the book Panic Disorder: Neurobiological and Treatment Aspects. 5 Still in the 1950s, Dr. Klein, a psychiatrist with a robust background in neurobiology, brought new rigor to the study of whether some psychiatric problems might have a biological basis that could be efficaciously treated with medications. At the time, psychotherapy was the go-to tool for treating depression and other mental problems, and the use of medications was somewhat haphazard. In other words, he played a central role in bringing psychiatry closer to other medical specialties. Emphasizing the importance of judicious scientific research, he utilized clinical observation, patient self-reports, assessment of pharmacological response, laboratory testing, and statistical analysis. His work helped refine or even create definitions for several psychiatric disorders, and, as a result, he helped establish the legitimacy of psychopharmacology as an adjunct to psychotherapy. This rigorous inquiry continued when Dr. Klein 6 reporting his discovery of panic attack blockade with imipramine in 1962, formulating concepts of panic disorder and agoraphobia, and addressing challenges in the physiology of panic disorder and separation anxiety 6, 7 ; ''False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis,'' 7 where he laid out the false suffocation alarm theory of panic disorder; and ''Panic, suffocation false alarms, separation anxiety and endogenous opioids,'' 8 a review of the false suffocation alarm theory which included the role of endogenous opioids. He established the main features of atypical depression 9 and demonstrated differential responses to treatment with imipramine, electroconvulsive therapy, and monoamine oxidase inhibitors. 10 He authored more than 500 peer-reviewed journal articles and more than 100 book chapters on the diagnosis and drug treatment of psychiatric disorders, received several major awards from various scientific societies worldwide, and, most importantly, was a mentor, teacher, and advisor to countless psychiatrists -ourselves among them.
Professor Donald Klein was a special person: unfailingly kind to everyone, slightly shy, but confident in his scientific and clinical claims. As with all great scientists, his vision was expansive, and his curiosity endless. A remarkable example for all of us trying to follow his teachings. His work and memory will be with us forever, and will inspire future generations as they look beyond. His are the shoulders they will stand upon.
Thank you, Don.
